Skip Navigation

Receive this page by email each issue: [Sign up for eTOCs]

Contents: Volume XXXIV, Supplement 4, January 1995   [Index by Author] 


Down Preface
Down Historical Overview
Down Mode of Action
Down Discussion
Down Clinical Experience
Down Discussion
Down Disease Outcome and the Case for Early Treatment in Rheumatoid Arthritis
Down Early Rheumatoid Arthritis
Down Discussion
Down Combination Therapy
Down Discussion


[Search ALL Issues]

Front Matter (PDF) | Back Matter (PDF)

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

Preface Back

Leo van de Putte and Michael Weinblatt
Preface
Rheumatology 1995 XXXIV: 1; doi:10.1093/rheumatology/XXXIV.suppl_4.1 [PDF] [Request Permissions]  

Historical Overview Back

R. S. Amos
The History of the use of Sulphasalazine in Rheumatology
Rheumatology 1995 XXXIV: 2-6; doi:10.1093/rheumatology/XXXIV.suppl_4.2 [Abstract] [PDF] [Request Permissions]  

Mode of Action Back

G. Smedegård and J. Björk
Sulphasalazine: Mechanism of Action in Rheumatoid Arthritis
Rheumatology 1995 XXXIV: 7-15; doi:10.1093/rheumatology/XXXIV.suppl_4.7 [Abstract] [PDF] [Request Permissions]  

H. A. Bird
Sulphasalazine, Sulphapyridine or 5-Aminosalicylic Acid—which is the Active Moiety in Rheumatoid Arthritis?
Rheumatology 1995 XXXIV: 16-19; doi:10.1093/rheumatology/XXXIV.suppl_4.16 [Abstract] [PDF] [Request Permissions]  

D. E. Furst
Practical Clinical Pharmacology and Drug Interactions of Low-Dose Methotrexate Therapy in Rheumatoid Arthritis
Rheumatology 1995 XXXIV: 20-25; doi:10.1093/rheumatology/XXXIV.suppl_4.20 [Abstract] [PDF] [Request Permissions]  

J. M. Kremer
Possible Mechanisms of Action of Methotrexate in Patients with Rheumatoid Arthritis
Rheumatology 1995 XXXIV: 26-29; doi:10.1093/rheumatology/XXXIV.suppl_4.26 [Abstract] [PDF] [Request Permissions]  

B. N. Cronstein
The Antirheumatic Agents Sulphasalazine and Methotrexate Share an Anti-Inflammatory Mechanism
Rheumatology 1995 XXXIV: 30-32; doi:10.1093/rheumatology/XXXIV.suppl_4.30 [Abstract] [PDF] [Request Permissions]  

Discussion Back

Sessions 1 and 2: Discussion
Rheumatology 1995 XXXIV: 33-34; doi:10.1093/rheumatology/XXXIV.suppl_4.33 [PDF] [Request Permissions]  

Clinical Experience Back

H. A. Capell
Clinical Efficacy of Sulphasalazine—a Review
Rheumatology 1995 XXXIV: 35-39; doi:10.1093/rheumatology/XXXIV.suppl_4.35 [Abstract] [PDF] [Request Permissions]  

P. L. C. M. van Riel, A. M. van Gestel, and L. B. A. van de Putte
Long-Term Usage and Side-Effect Profile of Sulphasalazine in Rheumatoid Arthritis
Rheumatology 1995 XXXIV: 40-42; doi:10.1093/rheumatology/XXXIV.suppl_4.40 [Abstract] [PDF] [Request Permissions]  

M. E. Weinblatt
Efficacy of Methotrexate in Rheumatoid Arthritis
Rheumatology 1995 XXXIV: 43-48; doi:10.1093/rheumatology/XXXIV.suppl_4.43 [Abstract] [PDF] [Request Permissions]  

D. M. Sandoval, G. S. Alarcón, and S. L. Morgan
Adverse Events in Methotrexate-Treated Rheumatoid Arthritis Patients
Rheumatology 1995 XXXIV: 49-56; doi:10.1093/rheumatology/XXXIV.suppl_4.49 [Abstract] [PDF] [Request Permissions]  

Discussion Back

Session 3: Discussion
Rheumatology 1995 XXXIV: 57-58; doi:10.1093/rheumatology/XXXIV.suppl_4.57 [PDF] [Request Permissions]  

Disease Outcome and the Case for Early Treatment in Rheumatoid Arthritis Back

T. Pincus
Long-Term Outcomes in Rheumatoid Arthritis
Rheumatology 1995 XXXIV: 59-73; doi:10.1093/rheumatology/XXXIV.suppl_4.59 [Abstract] [PDF] [Request Permissions]  

Early Rheumatoid Arthritis Back

D. M. F. M. van der Heijde
Joint Erosions and Patients with Early Rheumatoid Arthritis
Rheumatology 1995 XXXIV: 74-78; doi:10.1093/rheumatology/XXXIV.suppl_4.74 [Abstract] [PDF] [Request Permissions]  

A. Young
Short-Term Outcomes in Recent-Onset Rheumatoid Arthritis
Rheumatology 1995 XXXIV: 79-86; doi:10.1093/rheumatology/XXXIV.suppl_4.79 [Abstract] [PDF] [Request Permissions]  

P. Emery
Therapeutic Approaches for Early Rheumatoid Arthritis. How Early? How Aggressive?
Rheumatology 1995 XXXIV: 87-90; doi:10.1093/rheumatology/XXXIV.suppl_4.87 [Abstract] [PDF] [Request Permissions]  

Discussion Back

Discussion
Rheumatology 1995 XXXIV: 91; doi:10.1093/rheumatology/XXXIV.suppl_4.91 [PDF] [Request Permissions]  

Combination Therapy Back

H. E. Paulus
Clinical Trial Design for Evaluating Combination Therapies
Rheumatology 1995 XXXIV: 92-95; doi:10.1093/rheumatology/XXXIV.suppl_4.92 [Abstract] [PDF] [Request Permissions]  

H. J. Williams
Overview of Combination Second-Line or Disease-Modifying Antirheumatic Drug Therapy in Rheumatoid Arthritis
Rheumatology 1995 XXXIV: 96-99; doi:10.1093/rheumatology/XXXIV.suppl_4.96 [Abstract] [PDF] [Request Permissions]  

M. Farr and P. A. Bacon
How and When Should Combination Therapy be Used? the Role of an Anchor Drug
Rheumatology 1995 XXXIV: 100-103; doi:10.1093/rheumatology/XXXIV.suppl_4.100 [Abstract] [PDF] [Request Permissions]  

C. J. Haagsma, P. L. C. M. van Riel, and L. B. A. van de Putte
Combining Sulphasalazine and Methotrexate in Rheumatoid Arthritis: Early Clinical Impressions
Rheumatology 1995 XXXIV: 104-108; doi:10.1093/rheumatology/XXXIV.suppl_4.104 [Abstract] [PDF] [Request Permissions]  

J. B. Shiroky
Combination of Sulphasalazine and Methotrexate in the Management of Rheumatoid Arthritis—View Based on Personal Clinical Experience
Rheumatology 1995 XXXIV: 109-112; doi:10.1093/rheumatology/XXXIV.suppl_4.109 [Abstract] [PDF] [Request Permissions]  

Discussion Back

Discussion
Rheumatology 1995 XXXIV: 113; doi:10.1093/rheumatology/XXXIV.suppl_4.113 [PDF] [Request Permissions]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.